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Abstract
Background
Mass spectrometry-based metabolomic analysis depends upon the identification of spectral peaks by
their mass and retention time. Statistical analysis that follows the identification currently relies on
one main peak of each compound. However, a compound present in the sample typically produces
several spectral peaks due to its isotopic properties and the ionization process of the mass
spectrometer device. In this work, we investigate the extent to which these additional peaks can be
used to increase the statistical strength of differential analysis.
Results
We present a Bayesian approach for integrating data of multiple detected peaks that come from one
compound. We demonstrate the approach through a simulated experiment and validate it on ultra
performance liquid chromatography-mass spectrometry (UPLC-MS) experiments for metabolomics
and lipidomics. Peaks that are likely to be associated with one compound can be clustered by
the similarity of their chromatographic shape. Changes of concentration between sample groups can
be inferred more accurately when multiple peaks are available.
Conclusions
When the sample-size is limited, the proposed multi-peak approach improves the accuracy at
inferring covariate effects. An R implementation and data are available
at http://research.ics.aalto.fi/mi/software/peakANOVA/.
Keywords
ANOVA-type modeling, Bayesian modeling, Clustering, Mass spectrometry, Metabolomics, Lipidomics,
Nonparametric Bayes
Background
The study of changes in the levels of metabolites and lipids has become essential for the comprehensive
understanding of human health [1]. Chromatography-coupled mass spectrometry (MS) techniques have
become the standard method for characterizing the human metabolome [2] and lipidome [3]. The tech-
nique generates a spectrum of peaks describing the sample in the plane defined by the retention time from
the chromatograph and the mass-to-charge ratio from the mass spectrometer. Each peak in this plane
is either generated by an ion arising from one of the compounds present in the sample, or is an artifact
of the measurement without association to any of the compounds. The association between the peaks
and compounds is unknown a priori. The produced peak data are noisy: First, sample preparation in-
troduces sources of uncertainty that propagate to the analysis [4]. Second, the accuracy of the device
is limited [5] and it produces biases. Third, peak identification, annotation and pre-processing steps
produce additional layers of uncertainty [6]. The effect of errors at all these levels is exacerbated by
the “small n, large p” problem: experiments cover a very limited number of samples, n, while the set of
compounds measured, p, is potentially large.
However, there also is strong informative structure in the data: First, each compound may generate mul-
tiple adduct peaks [7] (Figure 1) and isotope peaks [8,9] (Figure 2), whose positions and shapes provide
information about the identity of the compound. Second, the concentrations of different compounds
generated by or participating in similar biological processes may be highly correlated [10]. An in-
creasing number of machine learning algorithms are being developed for inferring such structure either
from raw spectral data [11] or from processed intensity data [12]. The inference of covariate effects—
the differences between sample groups determined by the controlled covariates of the experiment, such
as an intervention—is in the core of the comparative analysis of spectral profiles [13]. In addition to
the controlled covariates, confounding factors may affect the observations and are subject to the experi-
ment design. In this work, we focus on inferring effects of the controlled covariates from the data.
Figure 1 A schematic of the positions of typical adduct peaks [7] in the RT-m/z plane for two lipids,
the ceramide Cer(d18:1/17:0) and the sphingomyelin SM(d18:1/22:0). An adduct peak is formed by
an ion attaching to the compound. At the finer detail, each peak in the figure consists of multiple isotope
peaks few atomic units apart, as shown for Cer(d18:1/17:0) in Figure 2. Even though the distinct isotope
peaks are not visible to the eye here, they are clearly separable by the mass spectrometer. In the figure,
adduct types and compounds are marked by colors and characters, respectively.
Figure 2 Natural isotopic distribution of the mass of a typical lipid, the ceramide Cer(d18:1/17:0).
The presence of atomic isotopes leads to the appearance of multiple mass spectral peaks from the com-
pound. Some isotopes are very similar by their mass but still differentiable by the mass spectrometer.
The isotope peaks have distinct mass-to-charge ratios at the same retention time (Figure 1).
The existence of additional peaks in the spectrum is usually seen as a problem and only the main peak
of each identified compound is used for further analysis. All peaks are a result of the ionisation process
where a charged particle is attached to or detached from a compound. Each such compound-ion pair
produces a distinct adduct peak. Random variation in the ionisation process leads to inconsistencies
between batches of samples, perceived as variation in the ratio of intensities of the peaks associated
with one compound. This is a major source of error for all existing analysis approaches regardless of
the choice of the peak used for the analysis. On the other hand, the distribution of the intensities of
isotope peaks is by nature well preserved across both samples and compounds. Moreover, the natural
isotopic distribution of a compound is known and can be used to make peak annotation more precise.
In this way, isotope peaks provide reliable additional information about the differences in compound
concentrations between sample groups.
We propose a probabilistic approach for extending statistical analysis to all available peaks and demon-
strate that the additional peaks can provide a real benefit to the inference of covariate effects (Figure 3).
The approach is used to cluster the peaks that are likely to arise from a single compound together and
to infer the changes in concentrations of the compounds more accurately based on all these peaks. By
this approach, we are addressing the problem of inadequate sample-size by introducing additional data
describing the compounds behind the noisy measurements.
Figure 3 Flow chart of the method. (a) Peaks are clustered by their shapes. (b) Covariate effects are
inferred based on the intensities of the clustered peaks.
To solve the problem we introduce the following assumptions about the generative process of the data
within a Bayesian model: First, samples carry between-group differences in their compound concen-
trations and the differences arise from responses to controlled covariates. Second, multiple observed
spectral peaks follow an identical generative process and their heights are a noisy reflection of the true
concentration level of the compound. Third, shapes of the peaks from one compound are generated
through an identical process following the properties of the measurement device, and thus these shapes
are highly similar.
The approach presented in this paper consists of two stages of computational inference: (1) peaks that
share a compound as their generative source are clustered together, and (2) the responses to controlled
covariates of the experiment are inferred on these clusters of peaks.
The clustering part of the approach is based on a nonparametric Bayesian Dirichlet process model [14].
To improve the performance of this model, we have redefined the prior distributions from a normal
distribution to a beta distribution to improve the match to the peak shape similarity observations.
The model for inferring the responses to covariates operates on clusters inferred in the first part. A Bayesian
multi-way model [13] is suitable for this task. This model itself could be used for clustering summa-
rized mass spectral intensity data, but in this work, we demonstrate that the clustering can be done more
accurately based upon the similarity of chromatographic peak shapes.
Methods
This section describing the models consists of two parts: clustering of spectral peaks and inference of
covariate effects. To maintain the mathematical rigor in the section, we use the terms “samples,” “vari-
ables” and “clusters” to refer to the experimental runs of the mass spectrometer, the peaks in the mass
spectrometry data, and the yet unknown compounds in the experimental runs, respectively. In the equa-
tions, we denote them by the indices
i =1, . . . , N (samples, i.e., experimental runs),
j =1, . . . , P (variables, i.e., peaks),
k =1, . . . ,K (clusters, i.e., compounds),
(1)
respectively, where N , P and K are their respective total numbers. We use bold capital, bold non-
capital and non-bold non-capital symbols to refer to matrices, vectors and scalars, respectively (e.g., V,
v and v).
Clusters of peaks based on the similarity
Following earlier work [14], we measure the similarity between the shapes of two peaks by their Pear-
son correlation computed over a window of retention time after a standard peak alignment [15] across
the samples. Truncating negative values to zero, this leads to a distinct similarity matrixQi·· ∈ [0, 1]P×P
for each sample i. In the notation, the operator “·” indicates that the entire dimension of the array is in-
cluded, not only the single item j. Since a peak is not necessarily observed in every sample, there may
be missing values in the matrices. Therefore, we construct an additional mask R ∈ {0, 1}N×P×P with
binary values rijj′ indicating whether the peak pair (j, j′) in sample i appears together within the win-
dow where the similarity is measured and whether both of the peaks are observed. An unidentified peak
may still be present in the sample below the limit of detection of the mass spectrometer. However, then
it is not useful for the inference of covariate effects and, thus, is treated as missing.
Model
We assume that the peaks are generated through a Dirichlet process [16]: there is an unknown number
of clusters and an unknown and variable number of peaks that arise from each of the clusters. Peaks are
assumed to have a one-out-of-many association: each peak is associated with only one of the unknown
clusters. With these basic assumptions, we can infer the P -by-K clustering matrix V from the data Q.
Value vjk = 1 in the clustering matrix V assigns the peak j to the cluster k. To make the following
equations more compact, we use an additional variable, εjj′ = vj·vTj′· ∈ {0, 1}, which is an inner prod-
uct of the cluster indicator vectors of the peaks j and j′, to denote whether the two peaks come from
the same or different clusters (1 or 0, respectively).
We set a spike-and-slab prior [17] for the peak shape similarity to model the inherent sparse structure
of the data. The similarity between any pair of observed peaks (j, j′) is assumed to follow a beta
distribution, but the shape of the distribution is assumed to depend on whether the pair comes from
the same cluster or from different clusters (shape parameters (ain, bin) or (aout, bout), when εjj′ = 1 or 0,
respectively). Also the probability of a missing similarity value is assumed to depend on the cluster
assignment of the pair (pin0 or pout0 , when εjj′ = 1 or 0, respectively). The distributional assumptions are
qijj′ |εjj′ ∼
{
rijj′
(
1− pin0
)
Beta
(
qijj′ |ain, bin
)
+ pin0 δ
(
rijj′
)
, εjj′ = 1,
rijj′ (1− p
out
0 )Beta
(
qijj′ |aout, bout
)
+ pout0 δ
(
rijj′
)
, εjj′ = 0,
(2)
with the first and the second row of the equation stating the distributions of a peak pair from the same
cluster and different clusters, respectively. The likelihood of the entire peak shape data,
L (Q,R|V) =
N∏
i=1
P−1∏
j=1
P∏
j′=j+1
p
(
qijj′ , rijj′ |εjj′
)
, (3)
becomes a product over all peak pairs and samples following the distributional assumption of Equation 2.
We further assume that the observed peaks are generated from an unknown finite subset of an infinite
set of clusters with an equal prior probability,
p
(
εjj′ = 1
)
=
1
P − 1 + αDP
, (4)
for any pair of peaks to be generated from the same cluster. These assumptions define the Dirichlet
process, controlled by the concentration parameter αDP, which determines the prior probability mass
outside the existing clusters. Following from this prior assumption, the probability of assigning peak j
to an existing cluster k,
p (vjk = 1|Q,R,V−j,·) ∝ skL (Q,R|V−j,·, vjk = 1) , (5)
becomes weighted by the current size of the cluster, sk = vT−j,kv−j,k. In the notation, matrices V·,−k
and V−j,· correspond to the matrix V with the column k and the row j omitted, respectively. Alterna-
tively, with probability
p (vj,K+1 = 1|Q,R,V) ∝ αDPL (Q,R|V−j,·, vj,K+1 = 1) , (6)
the process may create a new cluster with the index K+1 and only the peak j inside. Then, the likelihood
term is weighted by the Dirichlet process concentration parameter αDP, which can be seen as a pseudo-
count for the number of peaks outside the current K clusters.
Inference
We infer the posterior distribution of the clustering via Gibbs sampling, which results in a set of S
samples of the clusteringV(s), s = 1, . . . , S, from the true posterior distribution p (V|Q,R). The com-
putational complexity of a Gibbs iteration is O
(
KP 2
)
. Further analysis can operate on the entire
posterior distribution of the clustering through integration, or on a point estimate of the distribution.
We follow earlier work [18] and acquire a point estimate of the posterior distribution of the clustering
through finding the least-squares clustering (Section 1 in Additional file 1).
Covariate effects based on peak heights
Having inferred the grouping of similar peaks into clusters that each correspond to a compound, we
infer the differences in concentrations between sample groups for each cluster given the peak height
data X ∈ RP×N and the clustering V. Again, some values in the data may be missing.
Model
After a peak-specific centering based on the control group, the observed peak heights for each sample i
are assumed to be normally distributed with a cluster-specific mean xlat
·i :
x·i|V,x
lat,σ2 ∼ N
(
Vxlat
·i ,Λ
)
, (7)
where the diagonal matrix Λ contains the peak-specific variance parameters σ2 ∈ RP+. The cluster-
specific means are assumed to be normally distributed with a sample group-specific prior α,
xlat
·i |α, ai ∼ N (α·ai , I) , (8)
where ai ∈ {1, . . . , La} is an indicator of group membership (covariate level) for sample i and I is
a K-by-K identity matrix. The corresponding covariate effects are arranged into an K-by-La matrix α
and the effects are assumed to be independent and normally distributed,
α·l ∼
{
δ (α·l) , l = 1
N (0, I) , l = 2, . . . , La,
(9)
except for the first level, l = 1, which is defined as the baseline level and thus is fixed to zero. The model
is not limited to one covariate: the cluster-specific mean xlati· can be expressed as a sum of effects of
multiple covariates and their interaction effects (Section 1 in Additional file 1). Further, the model is
readily extensible for dependent covariate effects [19].
The peak-specific variance parameter,
σ2j ∼ Scale-Inv-χ2
(
n0, σ
2
0
)
, (10)
follows a scaled inverse-χ2 distribution with n0 prior samples and a scale σ20 .
Inference and analysis
We infer the covariate effects via Gibbs sampling. Now the clustering matrixV has been learned earlier,
and is thus taken as known in the model. Computational complexity of a Gibbs iteration is O
(
NPK2
)
.
The clustering and the covariate effects can be inferred overnight on a standard desktop computer for
a typical-sized data set. The posterior distributions of the covariate effects α are descriptive of the dif-
ferences between the sample groups and, thus, interesting from the analysis point of view. To assess
the significance of the difference between a sample group, c = l > 1, and the control group, c = 1, for
a cluster k, we can study the posterior probability of the effect αkl being greater or less than zero.
Comparison methods
We call the method described above Model 1. We compared the performance of the following ap-
proaches and refer to them as Models 1, 2 and 3:
1. the multi-peak approach using both peak shape and height information, as proposed in this work (non-
parametric clustering of peaks by their shape similarity, inference of covariate effects on the clus-
ters based on the height of the peaks),
2. the multi-peak approach using peak height information only [13] (clustering of peaks and infer-
ence of covariate effects based on the height of the peaks only),
3. the typical single-peak approach (inference of covariate effects by the height of the strongest
annotated peak only).
For the studied real data sets, we discovered that peak height information alone is not enough for cluster-
ing the peaks into individual compounds due to the high level of noise and strong correlations between
compounds. Thus, for real data we compared Model 1 to Model 3 and highlight the benefit gained by
using peak shape information.
Model 2 assumes the generative Gaussian latent variable model of the Equations 7–10 for the intensity
observationsX and a uniform multinomial prior for the clustering of the peaks. The clustering is inferred
by Gibbs sampling together with the covariate effects.
Model 3 quantifies the difference between the covariate level, c = l, and the control level, c = 1, as
the difference of their means based on the main peak j,
αj,l =
1∑N
i=1 δai,l
N∑
i=1
δai,lxj,i −
1∑N
i=1 δai,1
N∑
i=1
δai,1xj,i. (11)
The Kronecker delta function δai,l selects the samples that have the covariate level l by receiving
the value 1, when ai = l, and 0, otherwise. When the data are log-transformed, the mean difference cor-
responds to the fold change computed in many analysis platforms such as MZmine [15] and XCMS [6].
Experiments
We demonstrate the performance of the proposed method through three experiments: a simulated data
experiment, a spike-in benchmark experiment with known changes in concentrations, and a gene silenc-
ing experiment with measurements of the lipidome of cancer cells.
Evaluation measures
Evaluation of the performance on real data sets is not a trivial task, as there is no ground truth available:
neither the identity of the peaks nor the true effect sizes are known. Thus, we also used spike-in data,
where the true covariate effects are known, although only a small number of the peaks are annotated.
For the simulated and benchmark experiments, we computed the mean squared error (MSE) between
inferred and true covariate effects as an evaluation metric. As a result of the log-transformation of the in-
tensity data, we were quantifying relative changes between sample groups, independent of the average
height of each peak. In the model, we thus assumed that the change is preserved across the peaks of one
compound, in relative terms. The significance of the difference in the MSE of the proposed approach
and the comparison method was tested by the paired one-sided t-test. The false discovery rate was con-
trolled by the Benjamini-Hochberg step-up procedure [20]. Additionally for the simulated experiment,
we studied the inference of the statistical significance of effects, since the true distribution of the data
was known.
To assess the sensitivity of the approaches to noise in natural lipidomic data lacking a ground truth, we
used two types of indirect evaluation: First, we studied the consistency of the inferred covariate effects
given a prior assumption about their similarity. Second, we examined the robustness of the inferred
covariate effects to noise. Finally, we demonstrated differences between the multi-peak and single-peak
approaches through examples of qualitative analysis of annotated peak clusters.
Simulated data
We started by investigating the performance of the proposed approach on synthetic data, where the true
covariate effects are known. We focused on a usual task in exploratory analysis of biological data:
the detection of significant non-zero covariate effects. We measured the performance by the accuracy at
this task—the ratio of true positive and true negative significant differences among all effects. We used
the 95 % posterior quantiles to determine the significance. Additionally, we compared the approaches
by the MSE to the true effects and studied the performance of the two clustering models by computing
the normalized information distance (NID) [21] to the true clustering.
The approaches were tested across a set of potential experimental settings to study how the observation
of additional peaks and samples affects the performance. Simulated data were generated by assum-
ing the latent structure of Model 1. The following data parameters were varied on a grid: sample-
size N = 2× {3, 7, 15} and peak-specific noise σ2 = {1, 5}. Additionally, the number of peaks per
cluster was varied between 3, 7 and 15. Covariate effects α·2 = [2,−1, 0.5, 0, 0, 0, 0] were generated
for each data set. The experiment was repeated 100 times with independent data sets. The results are
reported in the Results and discussion section.
Benchmark data with known changes in concentrations
The benchmark data set of apple samples [22] includes a set of annotated spike-in compounds with
increases of 20, 40 or 100 % in concentrations. We started with the raw spectral data [23] in order to
acquire the shapes of the peaks in addition to their heights. The mass spectra were pre-processed using
MZmine 2 [15] (Section 4 in Additional file 1). We used standard pre-processing methodology also
used in the original publications of the data sets, thus maintaining the focus of the work on the potential
benefit gained from the multiple peaks. The compared approaches were on the same line in terms of
the data.
We evaluated the approaches by the MSE between inferred and true covariate effects. If the cluster
contained multiple annotated peaks, the effect of each annotated peak was evaluated separately for
the single-peak approach. Clusters with no annotated peaks were considered to have a 0 % true effect
and the effect of the single-peak approach was inferred based on the strongest peak of the cluster.
Lipidomic data from a gene silencing study
The data come from a recent experiment [24] to study the effects of gene silencing treatments on
lipidomic profiles and growth of breast cancer tissue. Driven by the lack of ground truth about the covari-
ate effects, we evaluated the inferred effects indirectly in two ways: (1) by quantifying the consistency of
the effects within a lipid family and (2) by quantifying the robustness of the magnitudes of the inferred
effects across the lipidome in presence of additional noise. Additionally, we investigated the stability of
the inferred clustering on the data and qualitatively analyzed differences between the covariate effects
of single peaks and the effects inferred on clusters of peaks by Model 1.
The data included 32 lipidomic profiles of breast cancer cells from the ZR-75-1 cell line. We inferred
the effects of seven distinct silencing interventions on metabolism- regulating genes (Section 5 in Ad-
ditional file 1) at two time points. The raw spectra were pre-processed with MZmine 2 as described in
the original publication [24], in addition to which the shape similarities of the peaks were computed.
Consistency of effect signs. In the first task, we quantified the consistency as the accuracy at pre-
dicting the covariate effect of a test lipid given the model on the covariate effects of other lipids of
the same family. For instance, we predicted the effect of a gene silencing treatment on the sphin-
gomyelin SM(d18:1/22:0) based on the sphingomyelin compounds in the training set. We examined
the sign of the effect instead of the absolute effect, since even within a family of lipids the changes have
a high variance and thus cannot be reliably predicted without imposing additional information about
the biological system.
We predicted the signs of the covariate effects for test lipids in a three-fold cross-validation setting
with 100 randomizations. The examined lipids included the annotated members from the three most
abundant families of lipids that had two or more peaks identified with the clustering model (Section 5 in
Additional file 1).
Further, we studied the influence of noise to the consistency by adding independent normally distributed
noise (from σ = 0 to σ = 10) on the peak intensity observations. Added noise variance σ = 1 was equal
to the existing original variance in the data, and the upper bound for the signal-to-noise ratio then was
0.5 (Additional file 1: Table S4).
Robustness of effect magnitudes. To evaluate the inferred effects at the scale of the entire observed
lipidome, we examined the consistency of inferred covariate effects between the original and noise-
added data sets. This experiment simulated the situation where the true effects are known (effects from
the original data set), but the data based on which the effects are inferred are noisy (the added-noise data
set). To measure the consistency, we computed the Spearman correlation between the covariate effects
inferred from the original and the added-noise data sets. We studied all clusters with two or more peaks,
constituting 20 % of the clusters.
Results and discussion
Simulated data
On a normal level of noise (σ2 = 1), the multi-peak approaches (Models 1 and 2) always performed
better at detecting significant covariate effects than the single-peak approach (Model 3; Figure 4a) and
only with enough samples the performance of Model 2 became comparable to Model 1. The inferred
clustering of Model 1 was perfect while the clustering performance of Model 2 heavily depended on
the number of samples available (Figure 4c).
Figure 4 The use of data from multiple peaks and the peak shape information increased the ac-
curacy at detecting significant covariate effects on simulated data. Accuracy of Models 1, 2 and 3
for simulated data is shown as a function of the sample-size in two settings: normal and high level of
noise (left: σ2 = 1, and right: σ2 = 5, respectively). Top (a-b): Accuracy at inferring the significance of
the generated covariate effects. Bottom (c-d): Normalized information distance (NID) between the in-
ferred and the true clustering. An entirely random and an exactly correct clustering correspond to a NID
of 1 and 0, respectively.
On a high level of noise (σ2 = 5), only Model 1 worked (Figure 4b). The reason for the failure of
Model 2 was the imperfectly inferred clustering (Figure 4d). The good performance of Model 1 resulted
from the clustering step, which is robust to noise in the peak heights. The peak shape similarity gave
strong evidence for inferring the clusters already from a single sample.
The MSE between the inferred and true covariate effects for Model 1 was smaller compared to Model 3
in all the 24 setups of the experimental grid (Additional file 1: Table S1). The difference was statistically
significant in 22 setups and in all setups at the high level of noise.
The performance of Model 1 clearly improved, when more peaks from a cluster were present in the data (Fig-
ure 5). This was pronounced at a high level of noise, when the observation of a single peak is unreliable
for inferring the covariate effects. In a similar way as in averaging over samples, the model is able to
overcome peak-specific noise also by averaging over multiple peaks.
Figure 5 The performance of Model 1 improved when more peaks per compound were available
in the simulated data. The curves show the accuracy as a function of sample-size for simulated data
with 15, 7 and 3 peaks per compound.
Benchmark data with known changes in concentrations
In the first demonstration on real UPLC-MS data [22], we show that Model 1 can infer the artificial
perturbations in a spike-in experiment more accurately than the single-peak approach.
In the positive ion mode, the model inferred 794 clusters, among which 135 clusters included more
than one peak. Seven clusters included annotated peaks from the spike-in compounds, four of which
included more than one annotated peak (Additional file 1: Table S2). Peaks from two compounds
were distributed to two and four clusters, respectively. In the negative ion mode, the model inferred
367 clusters, among which 113 clusters were non-singletons. Three clusters included annotated peaks
from the spike-in compounds, all of these clusters included more than one annotated peak and all peaks
from one compound were clustered together. In both the ion modes, all clusters with annotated peaks
were specific to one compound.
Model 1 had a lower error than Model 3 at all magnitudes of the true effect with the strongest relative
improvement occurring at the small magnitudes (Figure 6). The difference was statistically significant
for covariate effects from 0 to 40 % (Additional file 1: Table S3).
Figure 6 Model 1 had a more accurate quantification of the covariate effects for the spike-in com-
pounds as well as for the unchanged non-annotated compounds in the benchmark experiment.
Root-mean-square error (RMSE; y-axis) between the inferred and true covariate effects is smaller for
Model 1 (All peaks) than for the single-peak approach (Single peak) at all the magnitudes of the true
effect (x-axis). Differences were statistically significant for changes of 0 to 40 % (Additional file 1:
Table S3).
Lipidomic data from a gene silencing study
In the second demonstration on real UPLC-MS data [24], we show that Model 1 can infer more consis-
tent covariate effects in two ways even though the true effects are unknown.
Consistency and robustness of effects
When examining the consistency of effects within a lipid family, Model 1 was more consistent than
Model 3 at all levels of noise (Figure 7). When no noise was added and also at moderate levels of noise,
both approaches performed clearly better than expected by random chance. When noise was added,
Model 3 suffered more and its performance reduced to the random level more rapidly. Given the as-
sumption about the general similarity of lipids within a family is true, Model 1 inferred the covariate
effects more consistently.
Figure 7 Model 1 (All peaks) had a better accuracy at the prediction of signs of covariate effects
for previously unseen lipids in the lipidomic gene-silencing data set compared to Model 3 (Single
peak). The difference became pronounced when simulated noise was added to the data. The prediction
was based on the inferred covariate effects of compounds from the same lipid family and was done in
a cross-validation setting. In the task, the effects of the seven gene-silencing treatments were predicted
on the three most abundant families of lipids in two time points. Points σ = 0 and σ > 0 on the x-axis
show the prediction accuracy (y-axis) for the original data and the data with added noise, respectively.
When examining the robustness of effect magnitudes, Model 1 was more consistent than Model 3 when
noise was added to the data (Figure 8). The confidence intervals from the 100 randomizations did not
overlap at all at moderate levels of noise.
Figure 8 The covariate effects inferred by Model 1 (All peaks) were more robust to noise compared
to Model 3 (Single peak). At moderate levels of noise, which is the regime of many biological
experiments, the confidence intervals over 100 randomizations did not overlap at all. The robustness
was quantified as the Spearman correlation (y-axis) between the effects inferred from the noisy and
noise-free versions of the lipidomic gene silencing data set as a function of the level of noise (x-axis).
Stability
Since the proposed approach is sensitive to the inferred clustering of the data, we analyzed the stability
of the inferred clustering on biological data, using the lipidomic gene silencing data as a case study.
We tested the influence of the concentration parameter αDP in the Dirichlet process clustering model.
The clustering result for the lipidomic gene silencing data was robust to changes in the magnitude
of the concentration parameter (Additional file 1: Figure S2). As expected, the number of clusters
increased, when the preset value of the concentration parameter increased, but the relative change was
small.
Qualitative analysis
Finally, we give concrete examples of potential findings that the approaches can uncover and demon-
strate how analysis based on a single peak may lead to a different outcome depending on the choice of
the peak.
The intervention-driven changes of individual peaks from two lipids along with the covariate effects
inferred by Models 1 and 3 are shown in Figure 9. In the case of the sphingomyelin SM(d18:1/22:0),
there were strong covariate effects inferred by Model 3 but many of these effects became weaker when
inferred based on multiple peaks by Model 1. On the contrary, Model 3 inferred weak covariate effects
for the ceramide Cer(d18:1/17:0) but based on multiple peaks and Model 1, one of the effects was
actually among the top-5 % strongest effects across the observed lipidome.
Figure 9 Example clusters of peaks from the lipidomic gene silencing data with differences in
the covariate effects inferred based on a single peak and multiple peaks. The heat maps show
changes in the lipid concentrations driven by the gene silencing interventions (columns). Covariate
effects inferred by Models 3 and 1 using a single peak and all peaks, respectively, are shown on the two
bottom rows of each heat map. The log2 fold changes of each peak associated with the compound are
shown on the top rows. Changes that by the magnitude fall to the top-5 % across the entire observed
lipidome are highlighted by the symbol ”T.“ Top (a): The sphingomyelin SM(d18:1-22:0) with three
peaks. Many strong changes for SM(d18:1-22:0) became weaker when they were inferred based on
all three peaks. Bottom (b): The ceramide Cer(d18:1-17:0) with six peaks. The effect of the SCAP
silencing for Cer(d18:1-17:0) at 72 hours became strong when it was inferred based on all six peaks.
Conclusions
We have empirically demonstrated that a model-based integration of multiple peaks can lead to an im-
proved accuracy in the inference of covariate effects, and we introduced a novel method for this task.
While the sample-size is always restricted by external constraints such as the experiment budget or
the availability of suitable patients, the inference based on multiple peaks gives a shortcut to extracting
more information from the limited set of samples, thereby directly addressing the “small n, large p”
problem. However, some types of systematic measurement error, such as some batch effects, escape this
treatment and can only be reduced by introducing independent replicates. Based on the results presented
in this work, we argue that additional peaks are especially useful when the signal-to-noise ratio is low
and the differences between sample groups are small.
We suggest that all the detected peaks that can be associated with a compound should be taken into
account in the comparative analysis. This is possible through the two-step generative modeling approach
presented in this work: (1) by identifying the peaks that can be associated with one compound through
clustering the peaks based on their shape similarity and (2) by the inference of covariate effects on
the clusters, each representing one compound.
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